Candidates having M.Sc. / M.Tech / M.Pharm. / M.V.Sc. or equivalent qualification in Life Sciences or allied subjects (Biochemistry / Biotechnology / Virology / Bioinformatics / Computational Biology / Microbiology, etc.)

Degree or Diploma in Pharmacy (50%) & Registration in Pharmacy Registration Council.

M.Pharm / MS Pharm / Pharm.D / MSc or Equivalent with specialization in Biochemistry/ Biotechnology/Microbiology or Life sciences. 

M.Sc / M.Tech. in any field related to life sciences. Candidate must be NET / GATE qualified. Experience in molecular biology and structural biology techniques including cloning, expression, purification of proteins will be preferred

Graduate in Life Sciences from a recognized university; Three years work experience from a recognized institution. 

PhD in any area of Life Sciences or Masters with minimum three years of experience. Candidate with first author publication in a reputed journal will be preferred. 

First class in Masters Degree with specialization in Cancer Biology / Epigenetics / Molecular Biology / Cell Biology / Nanoscience and Nanotechnology from a recognized University with good knowledge of molecular biology.

Having good exposure in the OSD facility, documentation and handling equipment such as FBD / FBP / Glatt/ Fette/ Korsch)

Exposure to Leak Test/ Skid Operations/ Filling/ Vial Washing, Exp of Handling Isolator/ VHP Based Filling Area

Diploma/ B Tech, B.sc, MSc, B.Pharm, BTech or Masters in Biotechnology / Microbiology /Biochemistry

Implement and maintain quality control procedures within the QMS framework. Conduct thorough inspections and tests on products and materials at various stages of production

WALK-IN INTERVIEW for Diploma / D.Pharm/ B.Sc / MSc Production, Warehouse & Engineering (OSD Formulations)

Pfizer Inc. announced that it has filed a lawsuit against Metsera, Inc., its Board of Directors, and Novo Nordisk, S.A. in the Delaware Court of Chancery. The lawsuit includes claims for breach of contract, breach of fiduciary duty, and tortious interference in contract arising from Metseras alleged breach of its obligations under the merger agreement between Pfizer and Metsera.

Semaglutide significantly reduced major adverse cardiovascular events in patients with overweight or obesity with cardiovascular disease but without diabetes, as per recent research study conducted by University College London.

The U.S. Food and Drug Administration today announced actions to restrict the sale of unapproved ingestible fluoride prescription drug products for children. The FDA sent notices to four companies outlining the agencys intention to take enforcement action against those marketing unapproved fluoride-containing ingestible drugs labeled for use in children under age 3 or older children at low or moderate risk for tooth decay.

A multiple sclerosis patient in the UK was the first to receive CAR T cell therapy, invented by UCL researchers, in a clinical trial testing whether this personalised treatment can slow or even halt the progression of the disease.

MET-I-CON 2026, the 2nd International Conference on Future Trends and Opportunities in the Pharmaceutical World, aims to provide a dynamic platform for advancing pharmaceutical knowledge and innovation.

M.Sc. in Chemistry. Candidates having research experience in the area of catalysis / electrochemistry / in organic/ inorganic synthesis.